Published in J Surg Res on October 23, 2009
Whey protein enhances normal inflammatory responses during cutaneous wound healing in diabetic rats. Lipids Health Dis (2011) 1.06
Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil. Infect Genet Evol (2012) 0.94
Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype. Am J Pathol (2015) 0.88
Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers. PLoS One (2013) 0.87
Hyperglycemia-Induced Changes in Hyaluronan Contribute to Impaired Skin Wound Healing in Diabetes: Review and Perspective. Int J Cell Biol (2015) 0.86
Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing. J Vasc Surg (2013) 0.86
The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing. Genes (Basel) (2014) 0.86
Biochemical and biomechanical characterization of porcine small intestinal submucosa (SIS): a mini review. Int J Burns Trauma (2013) 0.85
Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring. Adv Wound Care (New Rochelle) (2015) 0.84
Sterile-filtered saliva is a strong inducer of IL-6 and IL-8 in oral fibroblasts. Clin Oral Investig (2014) 0.84
Increased skin inflammation and blood vessel density in human and experimental diabetes. Int J Low Extrem Wounds (2013) 0.84
Neurotensin modulates the migratory and inflammatory response of macrophages under hyperglycemic conditions. Biomed Res Int (2013) 0.81
Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast. Evid Based Complement Alternat Med (2013) 0.79
Age-related macular degeneration: beyond anti-angiogenesis. Mol Vis (2014) 0.79
Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds. Adv Wound Care (New Rochelle) (2015) 0.75
Wound healing and its impairment in the diabetic foot. Lancet (2005) 5.63
Macrophages and angiogenesis. J Leukoc Biol (1994) 3.85
Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes (1974) 2.77
Inflammatory mechanisms in the regulation of insulin resistance. Mol Med (2008) 2.71
Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev (2006) 2.30
Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol (1998) 2.09
Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72
Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr Diabetes (2008) 1.68
Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res (2002) 1.52
Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes (2003) 1.43
Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J (2006) 1.33
Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med (2009) 1.22
Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. Diabetologia (2003) 1.17
Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol (2006) 1.16
Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation. Biochem Biophys Res Commun (2007) 1.12
Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1. Diabetologia (2003) 1.06
Chemokines and diabetic wound healing. Vascular (2007) 1.03
Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med (2008) 1.02
A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds (2005) 0.93
Neurogenic factors in the impaired healing of diabetic foot ulcers. J Surg Res (2006) 0.91
Heterogenous changes in neuropeptide Y, norepinephrine and epinephrine concentrations in the hearts of diabetic rats. Auton Neurosci (2005) 0.87
Exercise-induced changes in neuropeptide Y, noradrenaline and endothelin-1 levels in young people with type I diabetes. Clin Physiol (1996) 0.79
Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation (2005) 5.07
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care (2004) 2.55
Noise-enhanced balance control in patients with diabetes and patients with stroke. Ann Neurol (2006) 2.06
Objective burden, resources, and other stressors among informal cancer caregivers: a hidden quality issue? Psychooncology (2011) 1.75
Staged total abdominal debranching and thoracic endovascular aortic repair for thoracoabdominal aneurysm. J Vasc Surg (2012) 1.74
Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care (2003) 1.68
Guidelines for the treatment of diabetic ulcers. Wound Repair Regen (2007) 1.67
Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg (2002) 1.59
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol (2010) 1.56
Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation (2002) 1.52
Contemporary results for proximal aortic replacement in North America. J Am Coll Cardiol (2012) 1.51
Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care (2003) 1.49
The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care (2002) 1.39
Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab (2009) 1.37
Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet (2005) 1.37
A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg (2003) 1.37
Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care (2002) 1.30
MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein. FASEB J (2008) 1.28
Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med (2009) 1.22
Retrograde ascending aortic dissection as an early complication of thoracic endovascular aortic repair. J Vasc Surg (2012) 1.22
Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes (2012) 1.21
MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res (2008) 1.19
Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J Am Heart Assoc (2013) 1.18
Comparison of gene silencing in human vascular cells using small interfering RNAs. J Am Coll Surg (2007) 1.14
Thoracoabdominal aortic aneurysm: hybrid repair outcomes. Ann Cardiothorac Surg (2012) 1.13
The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Diabetes Care (2007) 1.12
Foot small muscle atrophy is present before the detection of clinical neuropathy. Diabetes Care (2005) 1.10
Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg (2010) 1.09
The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Metab (2004) 1.06
The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes (2005) 1.05
Results with a selective revascularization strategy for left subclavian artery coverage during thoracic endovascular aortic repair. Ann Thorac Surg (2011) 1.03
In vivo acceleration of skin growth using a servo-controlled stretching device. Tissue Eng Part C Methods (2010) 1.03
Vascular dysfunction in obstructive sleep apnea and type 2 diabetes mellitus. Obesity (Silver Spring) (2010) 1.02
Transcriptional stimulation of the surfactant protein B gene by STAT3 in respiratory epithelial cells. J Biol Chem (2002) 1.00
O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS One (2010) 1.00
The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism (2003) 1.00
Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology. Diabetes Care (2010) 1.00
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation (2003) 0.99
Risk factors for 1-year mortality after thoracic endovascular aortic repair. J Thorac Cardiovasc Surg (2012) 0.99
DPP4 inhibitors: a new approach in diabetes treatment. Adv Ther (2008) 0.98
A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: modulation of cell migration and proliferation. J Vasc Surg (2007) 0.98
A decade experience with infrainguinal revascularization in a dialysis-dependent patient population. J Vasc Surg (2002) 0.97
Guidelines for the prevention of diabetic ulcers. Wound Repair Regen (2008) 0.96
High throughput RNAi assay optimization using adherent cell cytometry. J Transl Med (2011) 0.96
Obstructive sleep apnea and aging effects on macrovascular and microcirculatory function. Sleep (2010) 0.95
Results of thoracic endovascular aortic repair 6 years after United States Food and Drug Administration approval. Ann Thorac Surg (2012) 0.93
A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds (2005) 0.93
Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One (2013) 0.92
Degree of hypothermia in aortic arch surgery - optimal temperature for cerebral and spinal protection: deep hypothermia remains the gold standard in the absence of randomized data. Ann Cardiothorac Surg (2013) 0.91
Who tended to continue smoking after cancer diagnosis: the national health and nutrition examination survey 1999-2008. BMC Public Health (2012) 0.91
Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism (2004) 0.91
Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med (2012) 0.91
Patient navigation pilot project: results from the Community Health Advisors in Action Program (CHAAP). Ethn Dis (2010) 0.90
Antioxidants and CVD in diabetes: where do we stand now. Curr Diab Rep (2007) 0.89
Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factors. Obesity (Silver Spring) (2010) 0.88
Diabetic neuropathy and microcirculation. Curr Diab Rep (2003) 0.88
Proteome analysis of isolated perfused organ effluent as a novel model for protein biomarker discovery. J Proteome Res (2006) 0.88
Therapeutic interventions and oxidative stress in diabetes. Front Biosci (Landmark Ed) (2009) 0.87
Lower extremity minor amputations: the roles of diabetes mellitus and timing of revascularization. J Vasc Surg (2005) 0.87
Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). BMC Med Res Methodol (2013) 0.87
Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injury. PLoS One (2012) 0.86
Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing. J Vasc Surg (2013) 0.86
Results with selective preoperative lumbar drain placement for thoracic endovascular aortic repair. Ann Thorac Surg (2013) 0.86
Temporal genomics of vein bypass grafting through oligonucleotide microarray analysis. J Vasc Surg (2004) 0.85
Impaired distal thermoregulation in diabetes and diabetic polyneuropathy. Diabetes Care (2009) 0.85
Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg (2006) 0.84
Increased skin inflammation and blood vessel density in human and experimental diabetes. Int J Low Extrem Wounds (2013) 0.84
Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther (2014) 0.84
Current techniques to detect foot infection in the diabetic patient. Int J Low Extrem Wounds (2010) 0.83
Minimally invasive edge-to-edge mitral repair with or without artificial chordae. Ann Thorac Surg (2013) 0.83
Total serum bilirubin does not affect vascular reactivity in patients with diabetes. Vasc Med (2009) 0.83
Effect of hyperglycemia and neuropeptides on interleukin-8 expression and angiogenesis in dermal microvascular endothelial cells. J Vasc Surg (2011) 0.83
Management of acute type B aortic dissection. J Thorac Cardiovasc Surg (2012) 0.83
Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. J Vasc Surg (2006) 0.83
The efficacy of Apligraf in the treatment of diabetic foot ulcers. Plast Reconstr Surg (2006) 0.82
Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study. Am J Surg (2007) 0.82
Treatment of diabetic ulcers. Dermatol Ther (2007) 0.82
Microvascular changes in the diabetic foot. Int J Low Extrem Wounds (2006) 0.82
Preoperative cardiac evaluation does not improve or predict perioperative or late survival in asymptomatic diabetic patients undergoing elective infrainguinal arterial reconstruction. J Vasc Surg (2005) 0.82
The effect of aspirin and various iontophoresis solution vehicles on skin microvascular reactivity. Microvasc Res (2002) 0.82
Enhancing sensation in diabetic neuropathic foot with mechanical noise. Diabetes Care (2003) 0.82
Genome-wide DNA methylation analysis identifies a metabolic memory profile in patient-derived diabetic foot ulcer fibroblasts. Epigenetics (2014) 0.81
A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes. Ostomy Wound Manage (2002) 0.81
Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds. Tissue Eng Part C Methods (2015) 0.81
The evolving natural history of neurophysiologic function in patients with well-controlled diabetes. J Peripher Nerv Syst (2013) 0.81
Treating diabetic ulcers. Expert Opin Pharmacother (2011) 0.80
Impact of diabetes on vasculature: focus on nervous system. Curr Diabetes Rev (2005) 0.80
In vivo testing of an infection-resistant annuloplasty ring. J Surg Res (2005) 0.79
Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. J Vasc Surg (2013) 0.79
Classification, diagnosis, and treatment of diabetic foot ulcers. Wounds (2008) 0.79
Foot muscle energy reserves in diabetic patients without and with clinical peripheral neuropathy. Diabetes Care (2009) 0.79
Treatment for older prostate cancer patients: disparities in a southern state. Med Care (2010) 0.79
Topical methyl nicotinate-induced skin vasodilation in diabetic neuropathy. J Diabetes Complications (2003) 0.79
Local anesthesia reduces the maximal skin vasodilation during iontophoresis of sodium nitroprusside and heating. Microvasc Res (2003) 0.78